Chronic cerebral hypoperfusion (CCH) is also prevalent in elderly patients with AD and contributes to the pathophysiology of AD, involving amyloid-β (Aβ) overproduction, clearance impairment, Tau-hyperphosphorylation, neuroinflammation, oxidative stress, and neuronal loss. Here, MAPT is linked to Alzheimer disease.